HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism

Thyroid

Volumn 16, Issue 12, 2006, Pages 1221-1227

  Pichurin, Pavel ^a,c   Pham, Nancy ^d   David, Chella S ^b   Rapoport, Basil ^a   McLachlan, Sandra M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; HLA DR3 ANTIGEN; T LYMPHOCYTE ANTIGEN; THYROTROPIN RECEPTOR A SUBUNIT ADENOVIRUS; THYROTROPIN RECEPTOR ANTIBODY; THYROTROPIN RECEPTOR DNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ALGORITHM; ALLELE; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CAUCASIAN; CONTROLLED STUDY; EPITOPE MAPPING; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HLA SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPLEEN CELL;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD40; EPITOPES, T-LYMPHOCYTE; GRAVES DISEASE; HLA-DR3 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; RECEPTORS, THYROTROPIN; THYROTROPIN;

EID: 33846144169     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.1221     Document Type: Article

References (34)

1. Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, Dodson PM, Sheppard MC, Barnett AH, Franklyn JA, Gough SCL 1998 Linkage disequlibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 83:3394-3397.
2. Tomer Y, Davies TF 2000 The genetics of familial and non-familial hyperthyroid Graves' disease. In: Rapoport B, McLachlan SM (eds). Graves' disease: pathogenesis and treatment. Kluwer Academic Publishers, Norwell, MA: 19-41.
3. Kong YC, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hammerling GJ, David CS 1996 HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 184:1167-1172.
4. Kong YM, David CS, Lomo LC, Fuller BE, Motte RW, Giraldo AA 1997 Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 46:312-317.
5. Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP 2004 Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Clin Exp Immunol 137:503-512.
6. Guo J, McLachlan SM, Pichurin PN, Chen C-R, Phan N, Aliesky HA, David CS, Rapoport B 2005 Relationship between thyroid peroxidase T cell epitope restriction and antibody recognition of the autoantibody immunodominant region in HLA DR3 transgenic mice. Endocrinol 146:4961-4967.
7. Pichurin P, Chen CR, Pichurina O, David C, Rapoport B, McLachlan SM 2003 Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b. Thyroid 13:911-917.
8. Flynn JC, Rao PV, Gora M, Alsharabi G, Wei W, Giraldo AA, David CS, Banga JP, Kong YM 2004 Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA. Clin Exp Immunol 135:35-40.
9. Wicker LS, Cheng S-L, Nepom GT, Elliott JF, Freed DC, Bansal A, Zheng S, Herman A, Lernmark A, Zaller DM, Peterson LB, Rothbard JB, Cummings R, Whiteley PJ 1996 Naturally processed T cell epitopes from human glutamic acid decarboxylase identifed using mice transgeneic for the type I diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 98:2597-2603.
10. Congia M, Patel S, Cope AP, De Virgiliis S, Sonderstrup G 1998 T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci USA 95:3833-3838.
11. Rothbard JB, Taylor WR 1988 A sequence pattern common to T cell epitopes. EMBO 7:93-100.
12. Inaba H, Martin W, De Groot AS, Qin S, De Groot LJ 2006 Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. J Clin Endocrinol Metab 91:2286-2294.
13. Tomer Y, Concepcion E, Greenberg DA 2002 A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12:1129-1135.
14. Grewal IS, Flavell RA 1996. A central role of CD40 ligand in the regulation of CD4 + T-cell responses. Immunol Today 17:410-414.
15. Splawski JB, Fu SM, Lipsky PE 1993. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 150: 1276-1285.
16. Jacobson EM, Concepcion E, Oashi T, Tomer Y 2005 A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146: 2684-2691.
17. Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS 1997 HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest 100:2227-2234.
18. Chen C-R, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM 2003 The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. J Clin Invest 111:1897-1904.
19. Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M 2002 A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168:2789-2794.
20. Mittereder N, March KL, Trapnell BC 1996 Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70:7498-7509.
21. Chazenbalk GD, Jaume JC, McLachlan SM, Rapoport B 1997 Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera. J Biol Chem 272:18959-18965.
22. Chazenbalk GD, Wang Y, Guo J, Hutchison JS, Segal D, Jaume JC, McLachlan SM, Rapoport B 1999 A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies. J Clin Endocrinol Metab 84:702-710.
23. Morris JC, Bergert ER, McCormick DJ 1993 Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem 268:10900- 10905.
24. Pichurin P, Yan X-M, Farilla L, Guo J, Chazenbalk G, Rapoport B, McLachlan SM 2001 Naked thyrotropin receptor DNA vaccination: A TH1 T cell response in which interferon- γ production, rather than antibody, dominates the immune response in mice. Endocrinol 142:3530-3536.
25. Pichurin P, Pichurina O, Chazenbalk GD, Paras C, Chen CR, Rapoport B, McLachlan SM 2002 Immune deviation away from Th1 in interferon-gamma knockout mice does not enhance TSH receptor antibody production after naked DNA vaccination. Endocrinology 143:1182-1189.
26. Pichurin P, Schwarz-Lauer L, Braley-Mullen H, Paras C, Pichurina O, Morris JC, Rapoport B, McLachlan SM 2002 Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Thyroid 12:755-764.
27. Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM, Rapoport B 2003 Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine. J Immunol 170:3522-3527.
28. Pichurin PN, Chen C-R, Nagayama Y, Pichurina O, Rapoport B, McLachlan SM 2004 Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease. Clin Exp Immunol 135:391-397.
29. Pichurin PN, Pichurina O, Marians RC, Chen CR, Davies TF, Rapoport B, McLachlan SM 2004 Thyrotropin receptor knockout mice: studies on immunological tolerance to a major thyroid autoantigen. Endocrinology 145:1294-1301.
30. Chen CR, Aliesky H, Pichurin PN, Nagayama Y, McLachlan SM, Rapoport B 2004 Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/C-C57BL/6 hybrid mice. Endocrinology 145:4927-4933.
31. Saitoh O, Nagayama Y 2006. Regulation of Graves' hyperthyroidism with naturally occurring CD4 + CD25 + regulatory T cells in a mouse model. Endocrinology 147: 2417-2422.
32. Aliesky HA, Pichurin PN, Chen CR, Williams RW, Rapoport B, McLachlan SM 2006 Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice. Endocrinology 147:2789-2800.
33. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park DJ 2003 A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13:919-925.
34. Simmonds MJ, Heward JM, Franklyn JA, Gough SC 2005. The CD40 Kozak SNP: a new susceptibility loci for Graves' disease? Clin Endocrinol (Oxf) 63:232-233.